CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 5 of 11

Lupus Science & Medicine

Briefs 161–200 of 423 CurrentRheuma has covered from this journal, newest publication first

Latest from Lupus Science & Medicine

All coverage, newest first

  1. Lupus Sci Med

    Diagnostic implication of left atrial stiffness index in patients with SLE with left ventricular diastolic dysfunction

    Diagnostic or prognostic studyLupus & APS

  2. Lupus Sci Med

    Comparison of obinutuzumab and rituximab for treating neuropsychiatric lupus: a retrospective case-control study

    Case-control studyLupus & APS

  3. Lupus Sci Med

    Role of combination immunotherapy in restoring brain synergistic functional connectivity in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations

    Cross-sectional studyLupus & APS

  4. Lupus Sci Med

    Detection rate, demographic associations and clinical implications of anti-C1q antibody elevations across diverse disease states

    Cohort studyLupus & APS

  5. Lupus Sci Med

    Pharmacokinetics, effectiveness, tolerability and effect on quality of life of open-label tofacitinib for the treatment of moderately active mucocutaneous manifestations of SLE: results of a 76-week phase II study

    Research articleLupus & APS

  6. Lupus Sci Med

    Corneal confocal microscopy: a novel biomarker of small fibre neuropathy in SLE

    Cross-sectional studyLupus & APS

  7. Lupus Sci Med

    Enpatoran, a first-in-class, selective, orally administered toll-like receptor 7/8 inhibitor, in systemic and cutaneous lupus erythematosus: results from a randomised, placebo-controlled phase Ib study

    Randomized controlled trialLupus & APS

  8. Lupus Sci Med

    Administration of belimumab prior to standard immunosuppression in patients with early active lupus hinders accrual of new EULAR/ACR criteria within the first 12 months of treatment

    Cohort studyLupus & APS

  9. Lupus Sci Med

    Does social support reduce bodily pain among African American women with SLE? Findings from a randomised controlled trial

    Secondary analysisLupus & APS

  10. Lupus Sci Med

    Clinical characteristics and prognostic factors in adult macrophage activation syndrome: an observational study in a Chinese cohort

    Cohort studyAcross diseases

  11. Lupus Sci Med

    Significant glomerular IgM deposition predicts poorer kidney outcomes in lupus nephritis compared with other forms of immune complex deposits

    Cohort studyLupus & APS

  12. Lupus Sci Med

    Unmet needs and challenges in the diagnosis and management of antiphospholipid syndrome: a qualitative stakeholder study within the ReCONNET framework

    Research articleLupus & APS

  13. Lupus Sci Med

    Impact of rural residence on clinical outcomes in SLE: a systematic review

    Meta-analysisLupus & APS

  14. Lupus Sci Med

    Programme evaluation of Strategies to Embrace Living with Lupus Fearlessly (SELF): an evidence-based digital programme to build and improve lupus self-management skills

    Research articleLupus & APS

  15. Lupus Sci Med

    Dyspigmentation and scarring in cutaneous lupus erythematosus

    Cross-sectional studyLupus & APS

  16. Lupus Sci Med

    Prediction model for renal outcomes in Latin American Mestizo patients with pure proliferative lupus nephritis

    Cohort studyLupus & APS

  17. Lupus Sci Med

    Predictors of patient-reported outcomes phenotypes in SLE during remission: a cluster analysis approach

    Cross-sectional studyLupus & APS

  18. Lupus Sci Med

    Predictors of damage accrual in childhood-onset SLE: a retrospective analysis from a tertiary lupus centre in Türkiye

    Cohort studyPediatric

  19. Lupus Sci Med

    Epidemiology of patients with moderate-to-severe SLE in Sweden

    Cohort studyLupus & APS

  20. Lupus Sci Med

    NLR outperforms PLR in SLE diagnosis and prognosis: an AI-enhanced meta-analysis of 12 850 patients with ethnicity-specific cut-offs

    Meta-analysisLupus & APS

  21. Lupus Sci Med

    Perceptions of ageing among middle-aged and older adults with SLE: a single-centre cross-sectional study

    Cross-sectional studyLupus & APS

  22. Lupus Sci Med

    Characterisation of systemic lupus erythematosus associated with immune checkpoint inhibitors: a pharmacovigilance study using FAERS database

    Cohort studyLupus & APS

  23. Lupus Sci Med

    Clinical characteristics and treatment response of patients with SLE complicated with thrombotic thrombocytopenic purpura

    Cohort studyLupus & APS

  24. Lupus Sci Med

    Potential causal effect of SLE on osteoporosis, and the mediation effect: a Mendelian randomisation study

    Meta-analysisOsteoporosis

  25. Lupus Sci Med

    Risk of preterm delivery and early pregnancy hydroxychloroquine use from a Californian lupus cohort

    Cohort studyLupus & APS

  26. Lupus Sci Med

    Association of disease-modifying antirheumatic drug selection with hospitalised infection among youth with childhood-onset systemic lupus erythematosus

    Cohort studyPediatric

  27. Lupus Sci Med

    Breastfeeding determinants in Egyptian mothers with systemic lupus erythematosus or rheumatoid arthritis: a retrospective cohort study

    Cohort studyRA

  28. Lupus Sci Med

    Frequency-dependent and temporal variability of low-frequency fluctuations in patients with primary Sjögren’s syndrome

    Cross-sectional studySjögren's & overlap

  29. Lupus Sci Med

    TSPO PET/MR in neuropsychiatric lupus: neuroinflammatory metabolic signatures and diagnostic biomarkers

    Cohort studyLupus & APS

  30. Lupus Sci Med

    Vitamin D receptor expression level in patients with SLE and its relationship with vitamin D status, disease course and bone mineral density

    Cross-sectional studyLupus & APS

  31. Lupus Sci Med

    Cortical changes in women with systemic lupus erythematosus with mild cognitive impairment: a voxel-based morphometry and surface-based morphometry study

    Cross-sectional studyLupus & APS

  32. Lupus Sci Med

    Prevalence and determinants of vertebral fractures in a SLE cohort

    Cross-sectional studyOsteoporosis

  33. Lupus Sci Med

    Immunogenicity, safety and adverse events of sequential vaccination with a 10-valent pneumococcal conjugate vaccine (PCV10) and PPSV23 compared with PPSV23 alone in systemic lupus erythematosus

    Randomized controlled trialLupus & APS

  34. Lupus Sci Med

    Prevalence and incidence of systemic lupus erythematosus in Thailand based on national health data

    Cohort studyLupus & APS

  35. Lupus Sci Med

    Glycosylation of anti-dsDNA IgG correlates with organ involvement in treatment-naïve patients with systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  36. Lupus Sci Med

    Enhancing predictions of subclinical cardiac dysfunction in SLE patients through integrative machine learning analysis

    Case-control studyLupus & APS

  37. Lupus Sci Med

    Advancing treat-to-target in SLE: a pilot study using a clinical decision support system

    Research articleLupus & APS

  38. Lupus Sci Med

    Anti-ribosomal-P protein antibodies and systemic lupus erythematosus (SLE): in a cross-sectional study of Danish adult patients with SLE, no significant association is found between anti-ribosomal-P and neuropsychiatric SLE

    Cross-sectional studyLupus & APS

  39. Lupus Sci Med

    Disease activity trajectories in paediatric lupus and associations with socioeconomic factors and patient-reported pain

    Cohort studyPediatric

  40. Lupus Sci Med

    Endotoxaemia in childhood-onset systemic lupus erythematosus induces low-density granulocytes and extracellular traps of innate immune cells

    Cross-sectional studyPediatric

All 423 Briefs in ExploreShowing Briefs 161–200 of 423, newest first